Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.
Gest C, Mirshahi P, Li H, Pritchard LL, Joimel U, Blot E, Chidiac J, Poletto B, Vannier JP, Varin R, Mirshahi M, Cazin L, Pujade-Lauraine E, Soria J, Soria C.
Gest C, et al. Among authors: soria j, soria c.
Cancer Lett. 2012 Apr 28;317(2):207-17. doi: 10.1016/j.canlet.2011.11.026. Epub 2011 Nov 25.
Cancer Lett. 2012.
PMID: 22120672